Orphan designation: Humanised monoclonal antibody against P-selectin (crizanlizumab) Treatment of sickle cell disease, 09/08/2012 Withdrawn | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 May 2026 - 12:10

Orphan designation: Humanised monoclonal antibody against P-selectin (crizanlizumab) Treatment of sickle cell disease, 09/08/2012 Withdrawn

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-12-1034

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters